Lorem ipsum dolor sit
amet consectetur adipisicing elit.
Porro obcaecati cupiditate sequi voluptatem eos laborum modi ipsa, repellat voluptate vero, quo autem fugiat in quis? Commodi aliquam doloribus corrupti inventore.
If you thought 2023 was a blockbuster for the specialty drug pipeline, just wait until you see what’s happening in 2024.
“By year’s end, nearly 40 new specialty drugs will hit the market,” predicts market access expert, Susan Trieu, Pharm.D., in a new article featured in this week’s edition of Becker’s Hospital Review’s e-newsletter.
While the breakthroughs are exciting, they may bring new cost containment and clinica
l challenges to the hospital c-suite.
There are 5 areas to watch in this year, according to Dr. Trieu. Find out what’s in store and what you cannot ignore in 2024:
Read the article now by filling out the form to the right.
Download the Article Now:
2024 Drug Pipeline: 5 Trends Hospitals Can't Ignore
by Susan Trieu, PharmD
How Does Your Hospital Pharmacy Benefit?
-
-
IN-DEPTH ASSESSMENTS We review clinical and financial performance, regulatory requirements, compliance status, standards of practice, accreditation standards, policies and procedures, and more
-
-
GUIDANCE BY PHARMACY PRACTICE SPECIALISTS We advise your pharmacy while addressing performance barriers and introducing a culture of continuous improvement
-
-
CORRECTIVE ACTION PLANS We benchmark performance and identify opportunities
-
-
SPECIAL COMPLIANCE PROGRAM We deliver keen focus on 340B programs, USP 797/800, controlled substance risk, accreditation readiness, and more
-
-
LEVERAGE OUR YEARS OF EXPERIENCE CPS has delivered over 250 customized sterile compounding consultative assessments for diverse compounding operations
-
-
RECEIVE A COMPLETE SITE ASSESSMENT using our proprietary audit tool
-
-
RECEIVE A DETAILED EVALUATION OF STAFF AND SYSTEMS including personnel training and evaluation, an operational review, and more
-
-
FOLLOWING ASSESSMENT, CPS will deliver a written compliance report and a corrective action plan detailing findings and recommendations to bring your compounding pharmacy into regulatory compliance.
-
-
CPS WORKS WITH YOUR THIRD-PARTY ADMINISTRATORS to capture the claims which now meet the standards for inclusion in your 340B program
-
-
YOUR ORGANIZATIONAL REVENUE INCREMENTALLY IMPROVES FROM THIS PROCESS
Case Study: How Drew Memorial Slashed Total Drug Spend to <$20 PPD